http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1988914-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf32b60391b469c41e86c353437f5751
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-655
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-31
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-14
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-31
filingDate 2007-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f1d1e53a74355550597e0f3f4904d2ad
publicationDate 2008-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-1988914-A1
titleOfInvention Combination of somatostatin-analogs with different selectivity for human somatostatin receptor subtypes
abstract The present invention relates to a combination of two or more Somatostatin (SRIF) peptidomimetics (also referred to as Somatostatin- or SRIF-analogs) which have different selectivity for the human somatostatin receptor subtypes SSTR2 and SSTR5, the use of such combination in the treatment of a disease mediated by activation of somatostatin receptors, and to pharmaceutical compositions comprising such a combination.
priorityDate 2006-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396196
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136101008
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5753
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5754
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408603
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226424078
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396747
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12003067
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14747225
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16161315
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399210
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57214391
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6918026
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420612
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396746
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6400441
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57181882
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399670
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128829306
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411612
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226427978
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136141294
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71349
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136086677

Total number of triples: 54.